PI3K-IN-46

CAS No. 304645-61-2

PI3K-IN-46( —— )

Catalog No. M35823 CAS No. 304645-61-2

PI3K-IN-46 is a specific inhibitor of PI3Kγ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 256 Get Quote
10MG 375 Get Quote
25MG 545 Get Quote
50MG 766 Get Quote
100MG 1008 Get Quote
200MG 1368 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PI3K-IN-46
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3K-IN-46 is a specific inhibitor of PI3Kγ.
  • Description
    PI3K-IN-46 (Intermediate 4) is an intermediate in the synthesis of PI3K inhibitor (2-imino-azolinone-vinyl fused-benzene derivative) that can be used for the research of autoimmune disorders, cardiovascular diseases, and neurodegenerative diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    304645-61-2
  • Formula Weight
    255.3
  • Molecular Formula
    C13H9N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C1=CC2=C(C=C1)N=CC=C2)=C3C(=O)N=C(N)S3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rueckle T, et, al. 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors. US8106214B2.
molnova catalog
related products
  • mTOR inhibitor 9d

    mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.

  • A66

    A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.

  • LY294002

    A classic, broad-spectrum PI3K inhibitor with IC50 of 0.5/0.57/0.97 uM for PI3Kα/δ/β, respectively.